Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1044 (LINC01044) is a gene that encodes a long intergenic non-coding RNA, classified among the lincRNA subfamily of long non-coding RNAs[1][5]. LincRNAs are characterized as autonomous RNA transcripts longer than 200 nucleotides that do not overlap with protein-coding genes[3][7]. While the functions of specific lincRNAs are frequently tissue- or context-specific, as a class, they are known to modulate gene expression via diverse mechanisms including chromatin remodeling, transcriptional regulation, and stabilization of other RNA molecules[3][7]. There are no drugs known to directly interact with LINC01044, and it is not currently considered a canonical therapeutic target such as a receptor, enzyme, or transporter. Its biological roles, like many lincRNAs, are likely regulatory and may be involved in fine-tuning gene expression, but no specific disease association or biomarker application is documented in the current literature[1][3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1044 (LINC01044).